HIGH-EFFICIENCY IODINATION OF MONOCLONAL-ANTIBODIES FOR RADIOTHERAPY
- 1 June 1987
- journal article
- research article
- Vol. 28 (6) , 1034-1036
Abstract
A technique for labeling monoclonal antibodies (MoAb) with large activities of radioiodine using the reagent N-bromosuccinimide is described. This technique has been used to label three tumor-associated antibodies with an average labeling efficiency of > 90%. No significant damage to the antibody could be detected by enzyme linked immunosorbent assay (ELISA), performed immediately after the labeling procedure. Because high radiochemical purity can be achieved without the need postlabeling purification, the procedure is rapid and results in very low radiation doses to staff.This publication has 9 references indexed in Scilit:
- IMMUNOSCINTIGRAPHY OF COLON-CARCINOMA1984
- HIGH-LEVEL IODINATION OF MONOCLONAL-ANTIBODY FRAGMENTS FOR RADIOTHERAPY1984
- Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.Journal of Clinical Investigation, 1983
- Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissuesInternational Journal of Cancer, 1983
- IMAGING OF MELANOMA WITH I-131-LABELED MONOCLONAL-ANTIBODIES1983
- TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURSThe Lancet, 1982
- Use of n-Bromosuccinimide for the Iodination of Proteins for RadioimmunoassayAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1982
- Monoclonal antibodies to epithelium‐specific components of the human milk fat globule membrane: Production and reaction with cells in cultureInternational Journal of Cancer, 1981
- Establishment and characterization of a cell line of human breast carcinoma originPublished by Elsevier ,1979